Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 670-675, October 2008

Predictors of Mortality From Pump Failure and Sudden Cardiac Death in Patients With Systolic Heart Failure and Left Ventricular Dyssynchrony: Results of the CARE-HF Trial

  • Barry F. Uretsky, MD

      Affiliations

    • Cardiology Division, UTMB, Galveston, Texas
    • Corresponding Author InformationReprint requests: Barry F. Uretsky, MD, 1001 Townson Avenue, P.O. Box 17006, Fort Smith, AR 72917-7006.
  • ,
  • Kristian Thygesen, MD

      Affiliations

    • Aarhus University Hospital, Aarhus, Denmark
  • ,
  • Jean-Claude Daubert, MD

      Affiliations

    • Department of Cardiology, Hopital Pontchaillou, Rennes, France
  • ,
  • Erland Erdmann, MD

      Affiliations

    • Klinik III fur Innere Medizin der Universitat zu Koln; Cologne, Germany
  • ,
  • Nick Freemantle, PhD

      Affiliations

    • University of Birmingham, Edgbaston, United Kingdom
  • ,
  • Daniel Gras, MD

      Affiliations

    • Nouvelles Cliniques Nantaises; Nantes, France
  • ,
  • Lukas Kappenberger, MD

      Affiliations

    • Division of Cardiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
  • ,
  • Luigi Tavazzi, MD

      Affiliations

    • Istituto di Ricovero e Cura a Carratere Scientifico, Policlinico San Matteo, Pavia, Italy
  • ,
  • John G.F. Cleland, MD

      Affiliations

    • Department of Cardiology, Castle Hill Hospital, Kingston-upon-Hull, United Kingdom

Received 6 September 2007; received in revised form 23 May 2008; accepted 2 June 2008. published online 16 July 2008.

Abstract 

Background

Determining a specific death cause may facilitate individualized therapy in patients with heart failure (HF). Cardiac resynchronization therapy (CRT) decreased mortality in the Cardiac Resynchronization in Heart Failure trial by reducing pump failure and sudden cardiac death (SCD). This study analyzes predictors of specific causes of death.

Methods and Results

Univariate and multivariate analyses used 8 baseline and 3-month post-randomization variables to predict pump failure and SCD (categorized as “definite,” “probable,” and “possible”). Of 255 deaths, 197 were cardiovascular. There were 71 SCDs with a risk reduction by CRT of 0.47 (95% confidence interval 0.29–0.76; P = .002) with similar reductions in SCD classified as definite, probable, and possible. Univariate SCD predictors were 3-month HF status (mitral regurgitation [MR] severity, plasma brain natriuretic peptide [BNP], end-diastolic volume, and systolic blood pressure), whereas randomization to CRT decreased risk. Multivariate SCD predictors were randomization to CRT 0.56 (0.53–0.96, P = .035) and 3-month MR severity 1.82 (1.77–2.60, P = .0012). Univariate pump failure death predictors related to baseline HF state (quality of life score, interventricular mechanical delay, end-diastolic volume, plasma BNP, MR severity, and systolic pressure), whereas randomization to CRT and nonischemic cardiomyopathy decreased risk; multivariate predictors of pump failure death were baseline plasma BNP and systolic pressure and randomization to CRT.

Conclusion

CRT decreased SCD in patients with systolic HF and ventricular dyssynchrony. SCD risk was increased with increased severity of MR (including the 3-month value for MR as a time-dependent covariate) and reduced by randomization to CRT. HF death was increased related to the level of systolic blood pressure, log BNP, and randomization to CRT. These results emphasize the importance and interdependence of HF severity to mortality from pump failure and SCD.

Keywords: Cardiac resynchronization therapy, heart failure, prognosis, sudden cardiac death

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosures: Members of the Steering (J-CD, EE, NF, DG, LK, LT, JC) and Endpoints (KT, BFU) Committees received compensation for Cardiac Resynchronization in Heart Failure trial activities. Steering Committee members received speaking honoraria and research support. Data management and all statistical analyses were performed by sponsor-independent groups.

PII: S1071-9164(08)00176-0

doi:10.1016/j.cardfail.2008.06.001

Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 670-675, October 2008